Page last updated: 2024-10-25

ciprofloxacin and Convalescence

ciprofloxacin has been researched along with Convalescence in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Convalescence: The period of recovery following an illness.

Research Excerpts

ExcerptRelevanceReference
"Despite its excellent antimicrobial activity against salmonellae and its favorable pharmacokinetic profile, ciprofloxacin at a dosage of 750 mg orally twice daily had an unacceptably high failure rate in patients with acute salmonellosis and may have prolonged fecal excretion of salmonellae."2.67Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. ( Cassidy, JE; Giusti, R; Heelan, J; Mayer, KH; Neill, MA; Opal, SM; White, R, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neill, MA1
Opal, SM1
Heelan, J1
Giusti, R1
Cassidy, JE1
White, R1
Mayer, KH1

Trials

1 trial available for ciprofloxacin and Convalescence

ArticleYear
Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers.
    Annals of internal medicine, 1991, Feb-01, Volume: 114, Issue:3

    Topics: Acute Disease; Adult; Carrier State; Ciprofloxacin; Convalescence; Disease Outbreaks; Double-Blind M

1991